# Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration

> **NCT00813891** · PHASE4 · UNKNOWN · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 180 (estimated)

## Conditions studied

- Macular Degeneration
- Visual Acuity

## Interventions

- **DRUG:** Ranibizumab
- **DRUG:** Ranibizumab
- **DRUG:** Ranibizumab

## Key facts

- **NCT ID:** NCT00813891
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-01
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2008-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00813891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00813891, "Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00813891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*